Articles by Disease (Heart Valve Diseases)

Impact of the Fontan Operation on Organ Systems

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 19
Page: 205-214
Author(s): Miriam Michel*, Manuela Zlamy, Andreas Entenmann, Karin Pichler, Sabine Scholl-Bürgi, Daniela Karall, Ralf Geiger, Christina Salvador, Christian Niederwanger and Hideo Ohuchi

Computational and Experimental Progress on the Structure and Chemical Reactivity of Procyanidins: Their Potential as Metalloproteinases Inhibitors

Journal: Current Organic Chemistry
Volume: 23
Page: 1403-1420
Author(s): Ana María Mendoza-Wilson* and René Renato Balandrán-Quintana

Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?

Journal: Current Vascular Pharmacology
Volume: 17
Page: 573-578
Author(s): Evangelia Mareti*, Christina Ampatzi, Stavroula A. Paschou, Evangelia Voziki and Dimitrios G. Goulis

Follistatin-like 1 in Cardiovascular Disease and Inflammation

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19
Page: 1379-1389
Author(s): Marijn M.C. Peters, Timion A. Meijs, Wouter Gathier, Pieter A.M. Doevendans, Joost P.G. Sluijter, Steven A.J. Chamuleau and Klaus Neef*

Protective Effects of Phenylpropanoids and Phenylpropanoid-rich Essential Oils on the Cardiovascular System

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19
Page: 1459-1471
Author(s): Jorge M. Alves-Silva, Mónica Zuzarte*, Carla Marques, Henrique Girão and Lígia Salgueiro

Percutaneous Pulmonary Valve Implantation: Current Status and Future Perspectives

Journal: Current Cardiology Reviews
Volume: 15
Page: 262-273
Author(s): Bart W. Driesen*, Evangeline G. Warmerdam, Gert-Jan Sieswerda, Folkert J. Meijboom, Mirella M.C. Molenschot, Pieter A. Doevendans, Gregor J. Krings, Arie P.J. van Dijk and Michiel Voskuil

Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm – What Does the Evidence Show?

Journal: Current Vascular Pharmacology
Volume: 17
Page: 432-439
Author(s): Camilla Krizhanovskii * and Anders Franco-Cereceda

Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review

Journal: Current Vascular Pharmacology
Volume: 17
Page: 515-537
Author(s): Genovefa D. Kolovou*, Gerald F. Watts, Dimitri P. Mikhailidis, Pablo Pérez-Martínez, Samia Mora, Helen Bilianou, George Panotopoulos, Niki Katsiki, Teik C. Ooi, José Lopez-Miranda, Anne Tybjærg-Hansen, Nicholas Tentolouris and Børge G. Nordestgaard

Lipoprotein Subfractions in Patients with Acute Coronary Syndromes: Should we Reach Beyond LDL-C?

Journal: Current Vascular Pharmacology
Volume: 17
Page: 376-378
Author(s): Peter P. Toth

Novel Hypolipidaemic Drugs: Mechanisms of Action and Main Metabolic Effects

Journal: Current Vascular Pharmacology
Volume: 17
Page: 332-340
Author(s): Theodosios D. Filippatos*, Angelos Liontos, Eliza C. Christopoulou and Moses S. Elisaf